Role of endogenous nitric oxide in liver-specific functions and survival of cultured rat hepatocytes

被引:16
作者
Donato, MT
Ponsoda, X
O'Connor, E
Castell, JV
Gómez-Lechón, MJ
机构
[1] Hosp Univ La Fe, Ctr Invest, Unidad Hepatol Expt, E-46009 Valencia, Spain
[2] Fac Ciencias Biol, Dept Parasitol & Biol Cellular, E-46014 Burjassot, Spain
[3] Fac Med, Dept Bioquim & Biol Mol, E-46010 Valencia, Spain
关键词
D O I
10.1080/00498250110052111
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The role of endogenous nitric oxide in rat hepatocyte functionality and survival in cell culture was examined. Towards this aim, cytochrome P450 activities (CYP1A1/2, 2B1, 2A1, 2C11, 2D1, 2E1 and 3A1), liver-specific metabolic functions and cell survival were comparatively evaluated in hepatocytes isolated from the male Sprague-Dawley rat and/or cultured in control conditions or in the presence of N-omega-nitro-L-arginine methyl ester (NAME), an inhibitor of nitric oxide synthesis. 2. Suppression of nitric oxide production by NAME paralleled a substantial preservation of hepatocyte phenotype in culture. The presence of NAME was particularly important during isolation and/or the 6-24 h culture. By 24 h, beneficial effects were evident in parameters particularly unstable in culture (glycogen content, P450), whereas no changes were produced in well-preserved functions (glucose, urea and albumin synthesis, glutathione, drug-conjugating enzymes). 3. Long-term treatment of hepatocytes with NAME also produced a reduction in caspase 3 activation and in the percentage of spontaneous apoptotic cells, and an increase in cell survival and transcriptional activity as shown by attached cellular protein content and the protein-DNA ratio respectively. 4. In conclusion, inhibition of early endogenous nitric oxide formation is an efficient procedure for obtaining hepatocyte cultures with stable expression of differentiated functions, high cell survival and few signs of cell senescence.
引用
收藏
页码:249 / 264
页数:16
相关论文
共 48 条
[1]   Hepatic metabolism of diclofenac:: Role of human CYP in the minor oxidative pathways [J].
Bort, R ;
Macé, K ;
Boobis, A ;
Gómez-Lechón, MJ ;
Pfeifer, A ;
Castell, J .
BIOCHEMICAL PHARMACOLOGY, 1999, 58 (05) :787-796
[2]   ETHOXYPHENOXAZONES, PENTOXYPHENOXAZONES, AND BENZYLOXYPHENOXAZONES AND HOMOLOGS - A SERIES OF SUBSTRATES TO DISTINGUISH BETWEEN DIFFERENT INDUCED CYTOCHROMES-P-450 [J].
BURKE, MD ;
THOMPSON, S ;
ELCOMBE, CR ;
HALPERT, J ;
HAAPARANTA, T ;
MAYER, RT .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (18) :3337-3345
[3]  
CASTELL JV, 1985, XENOBIOTICA, V18, P737
[4]   TARGETS OF NITRIC-OXIDE IN A MOUSE MODEL OF LIVER INFLAMMATION BY CORYNEBACTERIUM-PARVUM [J].
CHAMULITRAT, W ;
JORDAN, SJ ;
MASON, RP ;
LITTON, AL ;
WILSON, JG ;
WOOD, ER ;
WOLBERG, G ;
VEDIA, LMY .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1995, 316 (01) :30-37
[5]   Nitric oxide in liver injury [J].
Clemens, MG .
HEPATOLOGY, 1999, 30 (01) :1-5
[6]  
DARZYNKIEWICZ Z, 1990, FLOW CYTOMETRY SORTI, P15
[7]  
DONATO MT, 1994, IN VITRO CELL DEV-AN, V30A, P825
[8]  
Donato MT, 1997, J PHARMACOL EXP THER, V281, P484
[9]   A MICROASSAY FOR MEASURING CYTOCHROME-P450IA1 AND CYTOCHROME-P450IIB1 ACTIVITIES IN INTACT HUMAN AND RAT HEPATOCYTES CULTURED ON 96-WELL PLATES [J].
DONATO, MT ;
GOMEZLECHON, MJ ;
CASTELL, JV .
ANALYTICAL BIOCHEMISTRY, 1993, 213 (01) :29-33
[10]  
DONATO MT, 1992, IN VITRO ALTERNATIVE, P149